Skip to content

Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Females

Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Females - Effects of Yogurt Drink containing AVGP (Aloe Vera Gel Powder) for Skin Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000019019
Enrollment
64
Registered
2015-09-16
Start date
2015-09-18
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin Function

Interventions

Sponsors

KSO Corporation
Lead Sponsor
Department of Dermatology, Wakayama Medical University
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Healthy Japanese females aged 30-60 years

Exclusion criteria

Exclusion criteria: [1]Individuals who use regularly cosmetology or food affecting to skin condition [2]Individuals who use cosmetics and creams except sunscreen on arm(s) [3]Individuals whose face and arm(s) have an abnormality requiring treatment [4]Individuals who contract allergic diseases with sleep deprivation or sleep disorder [5]Individuals who have skin disease [6]Individuals who excessively take alcohol [7]Individuals who is a smoker (smoking over 20 cigarettes/day) [8]Individuals who contract or have a history of serious skin disease, hepatopathy, kidney damage, heart disease, lung disease, endocrine disease, and metabolic disease [9] Individuals who have a history of drug allergy or serious food allergy [10]Individuals who are pregnant or breast-feeding, or have the will of pregnancy during the study period [11]Individuals who participate in other clinical studies [12]Individuals who have chronic constipation (defecation less than 3 times/week) in the past three months [13]Individuals judged inappropriate for the study by the principal by the results of subject background, physical findings, or medical examination

Design outcomes

Primary

MeasureTime frame
[1]Skin viscoelasticity [2]Transepidermal water loss [3]Water content of the skin [4]Collagen score (measuring with ultrasonic waves) [5]Wrinkles (corner of the eye)

Secondary

MeasureTime frame
[1]Observation for skin condition [2]Subjective symptom for skin condition

Countries

Japan

Contacts

Public ContactEiji Yoshikawa

KSO Corporation Sales department

yoshikawa@kso.co.jp03-3452-7733

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026